EX-10.14




 Exhibit 10.14 
  

					
			



		 Houston Technology Center

Suite 325
 410 Pierce
Street
 Houston, TX 77002

			 Phone: 832-431-3555

Fax: 858-756-0482
		

 December 8, 2014 

Sunil Chada, PhD 
 PSYGEN, Inc. 

[Address Removed] 
 Dear Sunil: 

This letter is to inform you that you are eligible to earn certain cash incentives as further described below (together, the “Combined
Bonus”). The Combined Bonus is to recognize your hard work and dedication to our goals and to continue to motivate you to achieve our goals, including the IPO of MultiVir Inc. (the “Company”). 

Cash Bonus #1 
 You will be eligible to
earn and be paid a cash bonus equal to up to $161,424.00, subject to required tax withholdings (the “IPO Bonus”). A portion of the IPO Bonus equal to (a) one-third of $3,363.00 multiplied by the number of completed calendar
months between March 1, 2014 and June 30, 2014 plus (b) one-half of $3,363.00 multiplied by the number of completed calendar months between June 30, 2014 (the “Measurement Date”) and the date of the IPO
(such amount the “IPO Bonus Amount”) will be earned and become payable upon an IPO, subject to your continuous Service through the IPO. That portion of the IPO Bonus Amount will be paid as soon as possible, but in no event later
than thirty (30) days, following the IPO. Except as provided in this letter, if your Service is terminated for any reason prior to the IPO, you will not receive any portion of the IPO Bonus. 

Notwithstanding the foregoing, if the Company terminates your Service for reasons other than for Cause prior to the IPO, and provided
(i) the Company does not offer you a Continuing Role, and (ii) you sign and do not revoke a Release that becomes effective and irrevocable no later than the Release Deadline, then you will earn and be paid a portion of the IPO Bonus equal
to the IPO Bonus multiplied by a fraction with a numerator equal to the number of completed calendar months between the Measurement Date and the date of the termination of your Service and a denominator equal to 48. Any portion of the IPO Bonus that
is earned as a result of this paragraph will be paid on the Release Deadline. If the Release does not become effective and irrevocable by the Release Deadline, you will not receive the IPO Bonus pursuant to the terms of this paragraph. For purposes
of clarification, if your Service is 

  
 1 









 
terminated by the Company prior to the IPO for Cause, or if you voluntarily terminate your continuous Service prior to the IPO for any reason, you will not receive the IPO Bonus. If the Company
offers you a Continuing Role and you decline such offer, then your Service will be deemed to have been voluntarily terminated by you and you will receive no portion of the IPO Bonus. For purposes of clarification, if you accept a Continuing Role
with the Company, your Service will not have terminated and you will remain eligible to receive the IPO Bonus Amount upon the IPO in accordance with the terms of this letter. 

The remainder of the IPO Bonus (that is, the amount of the IPO Bonus less the IPO Bonus Amount) will be eligible to be earned in equal monthly
installments of $3,363.00 on each monthly anniversary of the Measurement Date that occurs after the IPO until paid in full, subject to the minimum Stock Price requirement described below and provided that your Service has not been terminated for any
reason prior to such applicable vesting date (such monthly amount, the “Ongoing IPO Bonus Amount”). 
 If the
Company’s Stock Price (as defined below) is less than $4.68 on the scheduled vesting date, the Ongoing IPO Bonus Amount for that month will not be earned. Instead, such Ongoing IPO Bonus Amount will be eligible to be earned on the next
scheduled vesting date where the Company’s Stock Price is greater than or equal to $4.68. Ongoing IPO Bonus Amounts that are earned will be paid as soon as possible, but in no event later than thirty (30) days, following the date on which
they are earned. Except as provided in this letter, if your Service is terminated for any reason prior to earning any Ongoing IPO Bonus Amount, that unearned amount will be forfeited. 

For purposes of example only, assume the amount of your potential IPO Bonus was $150,000, your Measurement Date was March 1, 2014 and the
IPO occurs on February 15, 2015. As of the IPO, you would earn 11/48ths of the IPO Bonus (or $34,375), less applicable tax withholding. On each monthly anniversary of the Measurement Date thereafter until the four (4) year anniversary of
the Measurement Date, you would be eligible to receive $3,125 on the scheduled vesting date, provided that the Company’s Stock Price was greater than or equal to $4.68 on the scheduled vesting date and provided that your Service has not been
terminated prior to such applicable vesting date (except as provided in this letter). 
 Taking the example further, assume that on the
July 1, 2015 vesting date, the Company’s Stock Price is $4.65. You would not earn any portion of the Ongoing Stock Bonus Amount for that month. On August 1, 2015, assume further that the Company’s Stock Price is $4.75. Subject to
your continued employment with the Company through that date, you would earn $6,250 (which represents the monthly Ongoing IPO Bonus Amount that otherwise would have been earned on July 1, 2015 and the monthly Ongoing IPO Bonus Amount earned on
August 1, 2015), less applicable tax withholding, provided that your Service has not been terminated prior to such applicable vesting date (except as provided in this letter). 

For purposes of this letter, “Stock Price” will mean the average Fair Market Value (as such term is defined in the 2014 Stock Option
and Grant Plan) of the Company’s common stock for the thirty (30) trading days prior to the scheduled vesting date. 
 Any
reference in this letter to the $4.68 Stock Price shall be appropriately adjusted to reflect any stock split, stock dividend or other change in the shares of the Company’s common stock. 

  
 2 









 Cash Bonus #2 

You will be eligible to earn and be paid up to three cash bonuses, each equal to $13,450.33, subject to required tax withholdings (each, a
“Registration Bonus”) on the date each of Ad-p53, Ad-IL24 and Ad-VirRx007 is registered with the Food and Drug Administration (each such date, the “Registration Date”). In order to earn and be paid any Registration
Bonus, (i) your Service must not have been terminated by the Company for any reason prior to the Registration Date, and (ii) the Company’s Stock Price must be greater than or equal to $4.68 on the applicable Registration Date. If the
Company’s Stock Price is below $4.68 on the Registration Date, you will not be eligible to earn the applicable Registration Bonus until the first date thereafter on which the Company’s Stock Price is greater than or equal to $4.68. 

Any earned Registration Bonus will be paid as soon as possible, but in no event later than thirty (30) days, following the date on which
it is earned. Except as provided in this letter, if your Service is terminated for any reason prior to a Registration Bonus being earned, you will not earn or otherwise be entitled to receive that Registration Bonus. 

Sale Event 
 Notwithstanding the terms of
the foregoing Combined Bonuses, if there is a “Sale Event” of the Company (as such term is defined in the 2014 Stock Option and Grant Plan), and provided (i) your Service has not terminated for any reason prior to the completion of
the Sale Event, and (ii) that the per share common consideration paid to the Company’s stockholders as of the completion of the Sale Event is greater than or equal to $4.68, you will earn and be paid 100% of any unearned portion of the
Combined Bonus. Any portion of the Combined Bonus that is earned as a result of this paragraph will be paid as soon as possible, but in no event later than thirty (30) days, following the Sale Event. 

As a condition to and in consideration for any portion of the Combined Bonus, you must execute this letter and return it to the Company by
December 19, 2014. 
 Please sign this letter and return it to Nicholas Puro no later than December 19, 2014. 

If you have any questions regarding the foregoing, please contact Nicholas Puro at 646704-3704 or at npuro@multivir.com. 

 

	
	Sincerely,
	
	/s/ Nicholas Puro
	
	Nicholas Puro
	President and COO


 AGREED: 
  

	
	 /s/ Sunil Chada

	Sunil Chada

 Date: 12/09/2014 

  
 3